SML0177

AUDA

≥98% (HPLC)

• Synonym(e): 12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-dodecanoic acid
• Empirische Formel (Hill-System): C₂₃H₄₀N₂O₃
• CAS-Nummer: 479413-70-2
• Molekulargewicht: 392.58
• NACRES: NA.77
• PubChem Substance ID: 329825206
• UNSPSC Code: 12352200
• MDL number: MFCD12912267
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: ≥10 mg/mL at warmed to 60 °C
• storage temp.: −20°C
• SMILES string: OC(=O)CCCCCCCCCCCNC(=O)NC12C[C@@H]3C[C@@H](C[C@@H](C3)C1)C2
• InChI: 1S/C23H40N2O3/c26-21(27)10-8-6-4-2-1-3-5-7-9-11-24-22(28)25-23-15-18-12-19(16-23)14-20(13-18)17-23/h18-20H,1-17H2,(H,26,27)(H2,24,25,28)/t18-,19+,20-,23-
• InChI key: XLGSEOAVLVTJDH-UKBVAGSOSA-N

Beschreibung

Application

AUDA may be used in soluble epoxide hydrolase-mediated cell signaling studies.

AUDA has been used in the inhibition of epoxide hydrolase in human macrophages and in inhibition of tumor necrosis factor α (TNF-α)- induced phosphorylation in human aortic smooth muscle cells.

Biochem/physiol Actions

AUDA is a potent inhibitor of soluble epoxide hydrolase

Inhibition of soluble epoxide hydrolase by AUDA inhibits the metabolism of epoxyeicosatrienoic acids (EETs) and protects end-organs against the damaging effects of salt-sensitive hypertension.[1] AUDA also renders protection against myocardial ischemia-reperfusion injury[2] and cerebral ischemia.[3]

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable